Home/Filings/4/0001493152-22-020869
4//SEC Filing

Marchisotto Jill 4

Accession 0001493152-22-020869

CIK 0000894871other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:02 PM ET

Size

61.5 KB

Accession

0001493152-22-020869

Insider Transaction Report

Form 4
Period: 2022-01-01
Marchisotto Jill
Chief Marketing Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-01+25,86625,866 total
  • Exercise/Conversion

    Common Stock

    2022-03-01+2,15630,178 total
  • Exercise/Conversion

    Common Stock

    2022-05-01+2,15634,490 total
  • Tax Payment

    Common Stock

    2022-07-05$10.95/sh15,032$164,60023,769 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-04-012,15645,272 total
    Common Stock (2,156 underlying)
  • Award

    Stock Option (right to buy)

    2022-06-06+10,00010,000 total
    Exercise: $10.69From: 2023-06-06Exp: 2032-06-06Common Stock (10,000 underlying)
  • Award

    Restricted Stock Units

    2022-06-06+10,00010,000 total
    From: 2023-06-06Exp: 2032-06-06Common Stock (10,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-03-012,15647,428 total
    Common Stock (2,156 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-18+7,7357,735 total
    Exercise: $8.82Exp: 2029-10-30Common Stock (7,735 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-18+9191 total
    Exercise: $8.82Exp: 2030-12-31Common Stock (91 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-06-012,15540,961 total
    Common Stock (2,155 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-07-012,15638,805 total
    Common Stock (2,156 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-08-012,15636,649 total
    Common Stock (2,156 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-01+2,15628,022 total
  • Exercise/Conversion

    Common Stock

    2022-07-01+2,15638,801 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-02-012,15649,584 total
    Common Stock (2,156 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-18+4,5464,546 total
    Exercise: $8.82Exp: 2029-10-30Common Stock (4,546 underlying)
  • Exercise/Conversion

    Common Stock

    2022-04-01+2,15632,334 total
  • Exercise/Conversion

    Common Stock

    2022-06-01+2,15536,645 total
  • Exercise/Conversion

    Common Stock

    2022-08-01+2,15625,925 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-01-0125,86651,740 total
    Common Stock (25,866 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-03-184,5460 total
    Exercise: $16.50Exp: 2029-10-30Common Stock (4,546 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-03-187,7350 total
    Exercise: $16.50Exp: 2029-10-30Common Stock (7,735 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-03-18910 total
    Exercise: $13.20Exp: 2030-12-31Common Stock (91 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-03-1833,2600 total
    Exercise: $17.38Exp: 2031-02-18Common Stock (33,260 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-18+33,26033,260 total
    Exercise: $8.82Exp: 2031-02-18Common Stock (33,260 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-05-012,15643,116 total
    Common Stock (2,156 underlying)
Footnotes (14)
  • [F1]On February 9, 2022, the Company (formerly known as theMaven, Inc.) changed its name to The Arena Group Holdings, Inc., uplisted its common stock to the NYSE American, and began trading under the symbol "AREN."
  • [F10]The option was originally granted also on October 30, 2019. The shares of the Company's Common Stock underlying the options vest one-third on October 30, 2020, with the balance vesting monthly over the next 24 months.
  • [F11]The option was originally granted on December 31, 2020. The shares of the Company's Common Stock underlying the options vest one-third on December 31, 2021, with the balance vesting monthly over the next 24 months.
  • [F12]The option was originally granted on February 18, 2021. The shares of the Company's Common Stock underlying the options vest one-third on January 1, 2022, with the balance vesting monthly over the next 24 months.
  • [F13]The option was originally granted on June 6, 2022. The shares of the Company's Common Stock underlying the options vest one-third on June 6, 2023, with the balance vesting monthly over the next 24 months.
  • [F14]The RSU was originally granted on June 6, 2022. The shares of the Company's Common Stock underlying the RSU vest one-third on June 6, 2023, with the balance vesting monthly over the next 24 months.
  • [F2]Effective at 8:00 p.m. Eastern Time on February 8, 2022, the common stock of the Company, par value $0.01 (the "Common Stock"), underwent a reverse split of 1-for-22 (the "Reverse Stock Split"). All amounts of Common Stock and other securities listed herein, and all exercise prices of derivative securities, have been adjusted to reflect the effect of the Reverse Stock Split (even if the listed transaction occurred before the effective date of the Reverse Stock Split).
  • [F3]The Reporting Person acquired the shares of Common Stock pursuant to vested shares that were originally granted in a Restricted Stock Unit ("RSU") grant dated 2/18/2021. Each RSU represents a contingent right to receive 1 share of the Issuer's common stock.
  • [F4]Shares forfeited pursuant to tax withholding.
  • [F5]1/3 of the shares associated with the RSU vest on January 1, 2022, with the balance of shares associated with the RSU vesting in 24 equal monthly installments thereafter (in full shares, rounded as necessary)
  • [F6]The RSU was previously reported as covering 1,707,317 shares (prior to the Reverse Stock Split, which is equal to 77,606 shares post Reverse Stock Split).
  • [F7]Stock Option Repricing Program. On March 18, 2022 (the "Repricing Date"), the Compensation Committee of the Company unanimously approved a one-time repricing of certain stock options (the "Repricing") outstanding under the Company's 2016 Stock Incentive Plan and 2019 Equity Incentive Plan that had an exercise price above $8.82 per share (the "Underwater Stock Options"). As a result of the Repricing, the exercise price of the Underwater Stock Options was set to $8.82 per share, which was the closing sale price of the Company's Common Stock as listed on the NYSE American exchange on March 18, 2022, and which price represented the per share fair market value (the "FMV") on the Repricing Date.
  • [F8]Pursuant to the Repricing, the exercise price was reduced for 45,632 Underwater Stock Options held by the filer, For each of the filer's stock option grants, reporting guidance suggests this should be reported as two transactions to reflect the lowering of the exercise price to $8.82, whereby the Underwater Stock Options are disposed and the Repriced option are acquired.
  • [F9]The option was originally granted on October 30, 2019. The shares of the Company's Common Stock underlying the options vest one-third on October 30, 2020, with the balance vesting monthly over the next 24 months.

Documents

1 file

Issuer

Arena Group Holdings, Inc.

CIK 0000894871

Entity typeother

Related Parties

1
  • filerCIK 0001843647

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:02 PM ET
Size
61.5 KB